There are few data concerning the utility of symptoms and signs at fi rst presentation in predicting a diagnosis of ulcerative colitis (UC) or Crohn's disease (CD). We conducted a study to examine this issue in secondary care.
INTRODUCTION
Th e infl ammatory bowel diseases (IBD), which include ulcerative colitis (UC) and Crohn's disease (CD), are a group of disorders of the gastrointestinal (GI) tract of unknown etiology. Th e population prevalence of UC and CD are between 150 and 250 per 100,000 people (1) (2) (3) (4) (5) (6) . Patients present with symptoms such as abdominal pain, change in bowel habit, and rectal bleeding ( 7, 8 ) . However, these symptoms are common in patients who do not have IBD, such as irritable bowel syndrome or hemorrhoids ( 9,10 ).
As not all people who experience these symptoms will consult a doctor or be referred for investigation, there is therefore the potential for a diagnosis of IBD to be missed or delayed, due to confusion with non-organic lower GI conditions such as irritable bowel syndrome ( 11, 12 ) .
Data from population-based cohorts suggest that there may be a considerable lag time between onset of symptoms and a diagnosis of IBD being secured ( 13, 14 ) . Delays in diagnosis theoretically mean that there is the possibility of worsening disease activity and
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increased digestive damage due to a failure to institute appropriate therapy that may alter the natural history of the disease in a timely manner. Th is is supported by recent evidence, suggesting that the length of diagnostic delay correlates with stricture development and need for intestinal surgery ( 15 ) .
Th is delay in diagnosis may be avoided if doctors were more aware of which symptoms or signs were likely to be predictive of a diagnosis of IBD. However, there have been few studies, to our knowledge, to date, examining this issue. We have therefore conducted a study to assess the utility of individual symptoms and signs at fi rst presentation, as well as combinations of these, in predicting a histologically confi rmed diagnosis of UC or CD among a large cohort of unselected patients newly referred from primary care to secondary care for the assessment and investigation of lower GI symptoms.
METHODS

Participants and setting
We recruited consecutive unselected patients, aged ≥16 years, newly referred from primary care during a 4-year period for consideration of investigation of GI symptoms to the outpatient clinics of two hospitals in Hamilton, Ontario. Th e McMaster University Medical Center and St. Joseph's Healthcare provide secondary care services to a local population of 520,000. All new patients were potentially eligible, unless they could not understand written English, and were provided with a study information sheet at their initial clinic visit. As this was a questionnaire study, patients who agreed to participate were asked to provide written informed consent at that visit. Th e study was approved by the Hamilton Health Sciences and McMaster University research ethics board in January 2008, and recruitment continued through to December 2012. We have previously validated the Rome III criteria for irritable bowel syndrome and functional dyspepsia, and described the overlap between the functional bowel disorders, using this data set (16) (17) (18) .
Data collection and synthesis
Demographic and symptom data . All demographic and symptom data were collected prospectively at the initial clinic visit, and hence before referral for colonoscopy. We recorded age, gender, ethnicity, marital status, educational level, lifestyle (tobacco and alcohol use), height (in meters), and weight (in kilograms), which were used to calculate body mass index. Symptom data were collected using the Rome III diagnostic questionnaire for the adult functional GI disorders. Th is is a 93-item instrument, which has been validated previously ( 19 ) . We used the symptoms and signs from this questionnaire that may be the presenting features of IBD. Th ese included the following: presence of lower abdominal pain; presence of a feeling of incomplete emptying aft er a bowel movement; passage of ≥4 stools per day; presence of loose, mushy, or watery stools; presence of urgency; passage of mucus per rectum (PR); passage of blood in the stools; presence of anal pain; whether the patient had been told by their doctor that they were anemic; or weight loss of >5 kg over the last year. We also recorded whether there was a family history of CD or UC. As these were all newly referred patients in whom a fi nal diagnosis had not been reached, we did not use disease-specifi c IBD questionnaires such as the Mayo score or the CD activity index. All questionnaire data were entered into a database by a trained researcher who was not involved with the clinical care of the patient, thus ensuring assessors were blinded to symptom status. Colonoscopic and histopathological data . All included patients underwent complete colonoscopy to the cecum or terminal ileum, as part of routine clinical practice, using Pentax colonoscopes (Pentax Canada, Mississauga, ON) and following standard bowel preparation, using either polyethylene glycol or sodium picosulfate (depending on patient and physician preference). Th e responsible physician performing colonoscopic examinations was blinded to the questionnaire data for each patient. Findings were recorded using the endoPRO reporting system (Pentax Canada). Th ese reports were accessed by the study investigators in order to record the ultimate colonoscopic diagnosis for each included patient.
Biopsy specimens were obtained at the discretion of the responsible physician performing the colonoscopy. Th ese specimens were interpreted by experienced GI histopathologists, who were also blinded to the questionnaire data of the patient. Histolopathological fi ndings were recorded using the MEDITECH Healthcare Reporting System (Medical Information Technology, Westwood, MA) and this was accessed by the study investigators in order to record the ultimate histopathological diagnosis.
Th e reference standard to defi ne patients with IBD was those who exhibited fi ndings consistent with either CD or UC aft er histopathological examination of their biopsy specimens, according to accepted criteria ( 20 ) . Patients with lower GI symptoms with normal colonoscopy and normal histology, or those with any other organic lower GI disease at either colonoscopy (including colorectal carcinoma, stricture, evidence of radiation-induced colorectal disease, colorectal adenoma, or hemorrhoids), or on examination of biopsy specimens (colonic or rectal adenoc arcinoma, microscopic colitis, ischemic colitis, radiation enteropathy, or neuroendocrine tumor) served as controls without IBD.
Statistical analysis
In order to assess whether those who underwent colonoscopy were representative of all patients seen in the two GI outpatient clinics, demographic data were compared between those undergoing colonoscopy, who completed the symptom questionnaire, and those who completed the symptom questionnaire but did not undergo colonoscopy, using a χ 2 -test for categorical data and an independent samples t -test for continuous data, with a mean and s.d. Owing to multiple comparisons, a two-tailed P -value of <0.01 was considered statistically signifi cant for these analyses. Th ese statistical analyses were performed using SPSS for Windows version 21.0 (SPSS, Chicago, IL).
Th e aim of this study was to describe the performance of individual items from the clinical history, as well as combinations of these, in predicting the presence of true IBD, UC, or CD vs. the reference standard. Th e sensitivity, specifi city, and positive and negative likelihood ratios (LRs), and their 95% confi dence intervals (CIs) were calculated for each of these, using a Microsoft Excel spreadsheet (XP professional edition; Microsoft , Redmond, WA). Th e positive LR can be calculated from the formula: positive LR=sensitivity/(1−specifi city), while the negative LR is derived from the formula: negative LR=(1−sensitivity)/specifi city. As a guide, positive LRs above 10 are very useful in ruling in a disease and negative LRs below 0.1 are very useful in ruling out a disease ( 21 ) . Th ese calculations were checked using Meta-DiSc version 1.4 (Universidad Complutense, Madrid, Spain). We performed these analyses for all patients with IBD, and for UC and CD separately, using both those with normal colonoscopy and histology, and those with other organic lower GI disease as controls, in order to best refl ect the heterogeneous nature of patients consulting with lower GI symptoms in usual clinical practice.
Logistic regression models were conducted for all IBD patients, as well as UC and CD separately, to evaluate symptoms that independently predicted disease, and interaction terms were included for all signifi cant symptom predictors in the model in order to assess whether there were statistically signifi cant interactions between symptoms. Th e proportion of the variation in the data explained by the model was calculated using the Nagelkerke R 
RESULTS
Th ere were a total of 4,224 consecutive patients who gave informed consent and were recruited in to the study between January 2008 and December 2012 ( Figure 1 ). Th e mean age of recruited subjects was 47.6 years (range 16 to 93 years) and 2,617 (62.0%) were female. In total, 1,981 (46.9%) of these 4,224 patients underwent complete colonoscopic evaluation for their lower GI symptoms. Th e remaining patients were consulting with upper GI symptoms, or colonoscopy was deemed unnecessary in reaching a diagnosis by the responsible physician. Demographic data of the patients who had complete colonoscopy, compared with the 2,243 subjects who did not, have been described previously ( 16 ) . Briefl y, those undergoing colonoscopy were slightly older (48.9 vs. 46.1 years), of higher body mass index (27.3 vs. 26.7 kg/m 2 ), and were more likely to be White Caucasian (90.8% vs. 85.5%), but there were no other signifi cant diff erences.
Of those colonoscoped patients, 1,289 (65.1%) had colonic or rectal biopsies taken and 302 (15.2%) were found to have IBD, 104 (5.2%) with UC, 147 (7.4%) with CD, and 51 (2.6%) with IBD-U. Baseline demographic data of those with IBD, as well as the 1,679 patients without IBD, are provided in Table 1 . Th e 1,679 patients without IBD included 897 (53.4%) with both a normal colonoscopy and normal colonic biopsies, 468 (27.9%) with adenomatous or hyperplastic polyps, 162 (9.6%) with hemorrhoids, 49 (2.9%) with colorectal cancer, 33 (2.0%) with microscopic colitis, 15 (0.9%) with angiodysplasia, and 10 (0.6%) with radiation enteropathy.
Performance of symptoms and signs at fi rst presentation in predicting IBD
Th e performance of individual items, as well as combinations of these, in predicting a diagnosis of IBD (UC, CD, and IBD-U combined) is summarized in Table 2 . Positive LRs for individual items ranged from 1.18 for the presence of a feeling of incomplete emptying aft er a bowel movement at least most of the time to 2.30 for passage of stools more than four times per day at least most of the time. Negative LRs were of similar utility, ranging from 0.70 for the presence of blood in the stools to 0.96 for the presence of a feeling of incomplete emptying aft er a bowel movement at least most of the time.
When symptoms and signs were combined, the positive LRs improved ( Table 2 ) . A combination of having been told by a doctor they were anemic, weight loss of >5 kg in the last year, and passage of stools more than four times per day yielded a positive LR of 8.77; the presence of more than four stools per day, blood in the stools, and mucus PR yielded a positive LR of 5.56; and having been told by a doctor they were anemic and passage of stools more than four times per day gave a positive LR of 5.53. However, negative LRs were poor, ranging from 0.85 to 0.96, because of their low sensitivity, as few patients with IBD reported these symptom combinations. When we repeated the above analyses with controls split into two groups, those with an organic lower GI disease and those with no lower GI organic disease, the results were remarkably similar (data not shown). 
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Aft er logistic regression using all factors described in Table 2 , family history of IBD, younger age, urgency at least most of the time, passage of stools more than four times per day at least most of the time, i.e., ≥75% time, and having been told by a doctor they were anemic were independent predictors of IBD ( Supplementary  Table 1 online). None of the interaction terms were statistically signifi cant and the model explained only 30% of the variation in the data. Overall, the model had a sensitivity of 56% (95% CI: 49%-62%), a specifi city of 92% (95% CI: 90%-94%), a positive LR of 6.9 (95% CI: 5.2-9.1), a negative LR of 0.48 (95% CI: 0.41-0.55), and a diagnostic odds ratio of 14.3 (95% CI: 9.6-21.4).
Performance of symptoms and signs at fi rst presentation in predicting UC
Th e performance of individual items from the clinical history, as well as combinations of these, in predicting UC vs. the reference standard is provided in Table 3 . Individual items performed only modestly in predicting the presence of UC, with positive LRs ranging between 1.15 for the presence of lower abdominal pain at least once a week and 2.85 for passage of mucus PR at least most of the time, and negative LRs of between 0.53 for the presence of blood in the stools and 0.94 for the presence of a feeling of incomplete emptying aft er a bowel movement at least most of the time.
Combinations of items were slightly more promising ( Table 3 ). Having been told by a doctor they were anemic, weight loss of >5 kg in the last year, and passage of stools more than four times per day yielded a positive LR of 14.6; having been told by a doctor they were anemic and passage of stools more than four times per day gave a positive LR of 7.87; and the presence of more than four stools per day, blood in the stools, and mucus PR gave a positive LR of 7.38. Positive LRs were high, because few people without UC reported these combinations, meaning that specifi city ranged from 97.9% to 99.5%. However, in all instances the negative LRs for these combinations were poor, ranging between 0.85 and 0.93, because the number of people with UC reporting all of the required items was small, meaning that the sensitivities were low for all of these, ranging between 7.9% and 16.7%. We repeated all the above analyses with controls split into two groups, those with an organic lower GI disease and those with no lower GI organic disease, but the results were remarkably similar (data not shown).
A logistic regression model of all factors described in Table 3 found that family history of UC, passage of stools more than four times per day at least most of the time, i.e., ≥75% time, having been told by a doctor they were anemic, and blood in the stools were independent predictors of UC ( Supplementary Table 2 ). None of the interaction terms were statistically signifi cant and the model explained only 18% of the variation in the data. Overall, the model had a sensitivity of 11% (95% CI: 5%-19%), a specifi city of 98% (95% CI: 97%-99%), a positive LR of 6.2 (95% CI: 2.7-13.7), a negative LR of 0.91 (95% CI: 0.83-0.96), and a diagnostic odds ratio of 6.8 (95% CI: 2.8-16.4).
Performance of symptoms and signs at fi rst presentation in predicting CD
Th e performance of individual items, as well as combinations of these, in predicting a diagnosis of CD is summarized in Table 4 . Positive LRs for individual items were again modest at best, ranging from 1.02 for the presence of a feeling of incomplete emptying aft er a bowel movement at least most of the time to 2.18 for either a family history of CD or passage of stools more than for times per day at least most of the time. Negative LRs were of similar utility, ranging from 0.70 for loose stools at least 75% of the time to 1.00 for the presence of a feeling of incomplete emptying aft er a bowel movement at least most of the time.
Combinations of items performed better, although not as well as in UC. Having been told by a doctor they were anemic, weight loss of >5 kg in the last year, and passage of stools more than four times per day yielded a positive LR of 6.46; the presence of more than four stools per day, blood in the stools, and mucus PR yielded a positive LR of 5.67; and having been told by a doctor they were anemic and passage of stools more than four times per day gave a positive LR of 5.46. However, in all instances negative LRs were suboptimal ranging from 0.90 to 0.97, due to the low sensitivity of these combinations. Again, when we repeated all the above analyses with controls split into two groups, those with an organic lower GI disease and those with no lower GI organic disease, the observed LRs were broadly comparable (data not shown). A logistic regression model of all factors described in Table 4 found that family history of CD, loose stools ≥75% time, and having been told by a doctor they were anemic were 
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DISCUSSION
We have examined the utility of individual symptoms and signs at fi rst presentation, as well as combinations of these, in predicting a diagnosis of UC or CD vs. an accepted reference standard in a cohort of almost 2,000 unselected new referrals to secondary care with lower GI symptoms, who underwent complete colono scopy. Th e prevalence of IBD in our cohort, aft er investigation, was 15%. Th e study has demonstrated that individual items perform modestly at best in predicting a diagnosis of IBD, with positive LRs ranging from 1.18 to 2.30 and negative LRs from 0.70 to 0.96, when these. Th e performance of these items was not enhanced when they were used to distinguish between those with IBD and only those without organic lower GI disease at colonoscopy.
Strengths of this study include the large sample size, with over 1,900 individuals undergoing colonoscopy and providing all patients with IBD were analyzed together. Combinations of items were an improvement in terms of positive LRs, which in some cases were above 5, but negative LRs were poor in all instances due to the low sensitivities of these combinations, which were below 10% in some cases, because few patients with IBD reported all of complete symptom data, meaning that this is one of the largest studies to examine the utility of symptoms and signs at fi rst presentation in predicting a diagnosis of UC or CD conducted, to our knowledge, to date. Th e study was designed to adhere closely to the STARD guidelines for the reporting of studies of diagnostic accuracy, with consecutive patients recruited, assessors blinded, and an accepted reference standard used. We also performed subgroup analyses, with only those with no evidence of organic lower GI disease as the comparator group. Finally, the majority of patients we recruited were unselected referrals to secondary care and we used a heterogeneous group of patients with either no organic lower GI disease or an organic lower GI disease other than IBD as controls without IBD, meaning that the results are likely to be generalizable to gastroenterologists consulting with individuals with lower GI symptoms, in whom IBD may be suspected, in usual clinical practice. Weaknesses of the study include the fact that we did not perform colonoscopy in all individuals with lower GI symptoms, as part of the study design. Th is means that in some individuals who were not subject to colonoscopy, a diagnosis of IBD may have been missed. If these patients also endorsed the items from the clinical history that we studied, then the accuracy of these may have been underestimated. In addition, those who did undergo colonoscopy and provide complete symptom data were not entirely representative of the entire study population, with an over representation of White Caucasians, older individuals, and patients with a higher body mass index ( 16 ) . However, in most cases the absolute diff erences in demographic data between those undergoing colonoscopy and providing complete symptom data, and those who did not undergo colonoscopy were small. Finally, the questions that were contained within the questionnaire perhaps lacked suffi cient detail, in some instances, to be able to diff erentiate between IBD and other organic lower GI disease. An example would be passage of blood in the stools, where some physicians consulting with a patient with this symptom would inquire about exact color, and whether the blood was mixed in with the stools, in the toilet bowl, or on the toilet paper.
In addition, as the study was conducted in usual clinical practice, terminal ileal intubation was not mandated, nor did we perform small bowel investigations in all individuals, meaning that isolated CD in the proximal or distal ileum may have been misclassifi ed as the absence of IBD in some instances. However, the majority of CD patients will have either a colonic or ileocolonic distribution at diagnosis ( 22 ) ; hence, it is likely to be that the number of individuals misclassifi ed will be small. Th e questionnaire we used did not assess the presence of other symptoms or signs from the clinical history and examination that may be useful in predicting a diagnosis of IBD, such as nocturnal diarrhea, the presence of an abdominal mass, or fever. Finally, as this study was conducted within usual clinical practice, we did not mandate a minimum level of blood work, such as complete blood count or C-reactive protein, or measurement of fecal calprotectin levels. It may be that combining these, or other, biomarkers with items from the clinical history would have provided a greater ability to discriminate between patients with and without IBD.
Our fi nding that items from the clinical history performed only modestly in predicting a diagnosis of IBD, CD, or UC is not surprising. We have previously studied the utility of symptoms and signs in discriminating between functional and organic lower GI disease ( 23, 24 ) , including colorectal cancer and irritable bowel syndrome, and in most cases these have been disappointing. One method that can be used when clinical features are suboptimal in predicting the disease of interest is to concentrate on those symptoms or signs that have a high specifi city, as this can be used to rule in the disease of interest ( 25 ) . Applying this approach to our data would suggest that specifi city can be increased by using more than one item in almost any combination, or using data derived from computer models. However, all approaches that lead to specifi cities >98% have sensitivities <15% and this is unlikely to be diagnostically useful.
Other investigators have demonstrated that a delay in confi rming a diagnosis of IBD is associated with increased need for surgery, poorer treatment outcomes, reduced quality of life, and extension of disease ( 15, 26, 27 ) . Given the modest positive LRs of most of the symptoms we examined, an alternative approach to expedite a diagnosis is to use the presence of these symptoms as potential indicators of IBD, which then mandate further urgent work-up in the form of measurement of infl ammatory markers in stool and blood, rather than immediate referral for colonoscopy. Of the available markers, fecal calprotectin performs better than blood C-reactive protein or erythrocyte sedimentation rate in screening for IBD (28) (29) (30) .
Th e fi ndings of the current study demonstrate that symptoms and signs at fi rst presentation are not helpful in predicting a diagnosis of IBD as an entity, or either CD or UC separately. Future studies should evaluate biological markers in combination with symptoms, to improve the accuracy of diagnosing IBD. Th is may enable the development of referral criteria to better identify patients with a high likelihood of IBD, who warrant urgent investigation.
